medRxiv PreprintsInternational20 November 2026
Single-cell profiling reveals venom-specific T-cells associated with tolerance during immunotherapy
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Background: Venom immunotherapy (VIT) is well established, but the dynamics of the rare venom-specific T cells during treatment need to be investigated. Defining these responses may identify biomarkers and pathways associated with treatment-induced tolerance. Methods: We sampled nine wasp-allergic individuals before and 7 days and 6 months after initiation of VIT, and 5 non-allergic donors at one time point. Single-cell RNA sequencing of isolated venom-specific T cells was used to characterise changes to immunophenotypes and immune receptor repertoires during VIT. Results: We unveiled a broad
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Unmet needs of Polish patients with cystic fibrosis seen through the lens of crowdfunding20 November 2026
- Motherly Plus: Study Protocol of a Randomized Controlled Trial Evaluating a Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression20 November 2026
- Targeting memory consolidation in major depression via pharmacological slow-wave sleep promotion20 November 2026
- Epidemiology of Cardiac Structure and Function Among African Caribbeans in Tobago: A Population-based Cohort Study20 November 2026
- Depressive Symptom Trajectories and Incident Cognitive Impairment by Outcome Ascertainment20 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.